| 1 |
12770567 | Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia. | 2003 |
2 |
| 2 |
10525068 | Role of adenosine and N-methyl-D-aspartate receptors in mediating haloperidol-induced gene expression and catalepsy. | 1999 Nov |
3 |
| 3 |
9736759 | Atypical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regions. | 1998 Sep 15 |
4 |
| 4 |
8995332 | Comparison of neurotensin responses to MDL 100,907, a selective 5HT2A antagonist, with clozapine and haloperidol. | 1997 |
1 |
| 5 |
9298921 | Differential effect of haloperidol on release of neurotensin in extrapyramidal and limbic systems. | 1997 Jul 30 |
8 |
| 6 |
9342379 | Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice. | 1997 Oct 28 |
2 |
| 7 |
7675173 | C-fos mediates antipsychotic-induced neurotensin gene expression in the rodent striatum. | 1995 Jul |
3 |
| 8 |
1349254 | Pharmacological specificity of the increase in neurotensin concentrations after antipsychotic drug treatment. | 1992 Mar 20 |
1 |
| 9 |
2006695 | Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients. | 1991 Apr |
1 |